Vir Biotechnology, Inc. (VIR) ownership: Top institutional holder: BlackRock, Inc. ($161.27M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 17998329.00 | $161.27M | 2026-03-31 |
| ARCH Venture Management, LLC | 12916663.00 | $115.73M | 2026-03-31 |
| SB INVESTMENT ADVISERS (UK) LTD | 10948093.00 | $98.09M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 9215577.00 | $82.57M | 2026-03-31 |
| GSK plc | 8550954.00 | $76.62M | 2026-03-31 |
| VANGUARD GROUP INC | 12548944.00 | $75.67M | 2025-12-31 |
| STATE STREET CORP | 7141094.00 | $63.98M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5382103.00 | $48.22M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-11 | |
| Sell | null | 2026-08-11 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 | |
| Sell | null | 2026-05-27 |
Back to VIR overview · VIR earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.